Urinary bladder collision tumors: A case report and literature review

Omar,Sami S.; Fakhralddin,Saman S.; Ali,Rawa M.; Abdullah,Ari M.; Tahir,Soran H.; Muhammed,Bryar Othman; Kakamad,Fahmi H.; Qadir,Abdullah A.; Abdullah,Hiwa O.; Abdalla,Berun A.; Kakamad,Suhaib H.; Hama,Jihad Ibrahim

doi:10.3892/mi.2025.225

May-June 2025 Volume 5 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

May-June 2025 Volume 5 Issue 3

Full Size Image

Case Report Open Access

Urinary bladder collision tumors: A case report and literature review

Authors:
- Sami S. Omar
- Saman S. Fakhralddin
- Rawa M. Ali
- Ari M. Abdullah
- Soran H. Tahir
- Bryar Othman Muhammed
- Fahmi H. Kakamad
- Abdullah A. Qadir
- Hiwa O. Abdullah
- Berun A. Abdalla
- Suhaib H. Kakamad
- Jihad Ibrahim Hama
View Affiliations / Copyright

Affiliations: Kscien Organization for Scientific Research (Middle East Office), Sulaymaniyah 46001, Iraq, Department of Scientific Affairs, Smart Health Tower, Sulaymaniyah 46001, Iraq, Smart Health Tower Raparin, Rania, Sulaymaniyah 46001, Iraq, Research Center, University of Halabja, Halabja 46018, Iraq

Copyright: © Omar et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 26
|
Published online on: March 7, 2025

https://doi.org/10.3892/mi.2025.225
Expand metrics +

Abstract

A collision tumor of the urinary bladder refers to a very rare condition in which two distinct types of tumors occur simultaneously within the same bladder. The present study reports the case of a patient with a collision tumor in the urinary bladder. A 43‑year‑old female patient was referred following a diagnosis of bladder carcinoma. The patient had previously undergone a cystoscopy‑directed transurethral resection of a bladder tumor (TURBT) to remove a mass from the urinary bladder. A biopsy revealed that the tumor was a moderately differentiated T2‑adenocarcinoma. A contrast‑enhanced computed tomography (CT) scan revealed an irregular, thickened bladder wall. Based on the PET scan result and the initial TURBT result, which revealed T2‑stage adenocarcinoma, a radical cystectomy was recommended. The final histopathological diagnosis was poorly differentiated adenocarcinoma (pT2 N0 M0) and well‑differentiated squamous cell carcinoma T1 N0 M0 as a collision tumor. In addition, the present study also provides a literature review which summarizes cases of urinary bladder collision tumors in male patients aged 50 to 74 years, primarily presenting with hematuria. Diagnoses were confirmed using imaging techniques, such as CT scans and MRIs. Surgical treatments, including TURBT and radical cystectomy, are commonly used, with some cases also receiving chemotherapy or immunotherapy. Outcomes varied, with some patients experiencing recurrence or metastasis, while others remained recurrence‑free post‑surgery. A bladder collision tumor is a rare disease; extensive radiological study and careful examination of the biopsy are required to diagnose the condition.

View Figures

View References

1	Abdullah AM, Qaradakhy AJ, Ali RM, Ali RM, Mahmood YM, Omar SS, Nasralla HA, Muhialdeen AS, Saeed YA, Dhair HM and Mohammed RO: Thyroid collision tumors: A systematic review. Barw Medical J. 2:44–56. 2024.
2	Gandhi JS, Pasricha S and Gupta G: Collision tumor of the urinary bladder comprising large cell neuroendocrine carcinoma and adenocarcinoma. Asian J Oncol. 3:144–146. 2008.
3	Miyazaki J and Nishiyama H: Epidemiology of urothelial carcinoma. Int J Urol. 24:730–734. 2017.PubMed/NCBI View Article : Google Scholar
4	Radović N, Turner R and Bacalja J: Primary ‘pure’ large cell neuroendocrine carcinoma of the urinary bladder: A case report and review of the literature. Clin Genitourin Cancer. 13:375–e377. 2015.PubMed/NCBI View Article : Google Scholar
5	Rouanne M, Loriot Y, Lebret T and Soria JC: Novel therapeutic targets in advanced urothelial carcinoma. Crit Rev Oncol Hematol. 98:106–115. 2016.PubMed/NCBI View Article : Google Scholar
6	Ploeg M, Aben KK, Hulsbergen-van de Kaa CA, Schoenberg MP, Witjes JA and Kiemeney LA: Clinical epidemiology of nonurothelial bladder cancer: Analysis of the Netherlands Cancer Registry. J Urol. 183:915–920. 2010.PubMed/NCBI View Article : Google Scholar
7	Tavora F and Epstein JI: Bladder cancer, pathological classification and staging. BJU Int. 102:1216–1220. 2008.PubMed/NCBI View Article : Google Scholar
8	Loriot Y, Necchi A, Park SH, Garcia-Donas J, Huddart R, Burgess E, Fleming M, Rezazadeh A, Mellado B, Varlamov S, et al: Erdafitinib in locally advanced or metastatic urothelial carcinoma. N Engl J Med. 381:338–348. 2019.PubMed/NCBI View Article : Google Scholar
9	Catto JW, Yates DR, Rehman I, Azzouzi AR, Patterson J, Sibony M, Cussenot O and Hamdy FC: Behavior of urothelial carcinoma with respect to anatomical location. J Urol. 177(1715)2007.PubMed/NCBI View Article : Google Scholar
10	Jiang W, Pan C, Guo W, Xu Z, Ni Q and Ruan Y: Pathologic collision of urinary bladder urothelial carcinoma with small cell carcinoma: A case report. Diagnostic Pathology. 18(80)2023.PubMed/NCBI View Article : Google Scholar
11	Abdullah HO, Abdalla BA, Kakamad FH, Ahmed JO, Baba HO, Hassan MN, Bapir R, Rahim HM, Omar DA, Kakamad SH, et al: Predatory Publishing Lists: A Review on the Ongoing Battle Against Fraudulent Actions. Barw Med J. 2:26–30. 2024.
12	Prasad S, Nassar M, Azzam AY, García-Muro-San José F, Jamee M, Sliman RKA, Evola G, Mustafa AM, Abdullah HO, Abdalla BA, et al: CaReL guidelines: A consensus-based guideline on case reports and literature review (CaReL). Barw Med J. 2:13–19. 2024.
13	Brinton JA, Ito Y and Olsen BS: Carcinosarcoma of the urinary bladder. A case report and review of the literature. Cancer. 25:1183–1186. 1970.PubMed/NCBI View Article : Google Scholar
14	Chen X, Ge H, Yang J, Huang B and Liu H: Primary malignant melanoma of the bladder collides with high grade non invasive urothelial papillary carcinoma: A case report. Oncol Lett. 24:1–5. 2022.PubMed/NCBI View Article : Google Scholar
15	Kitazawa M, Kobayashi H, Ohnishi Y, Kimura K, Sakurai S and Sekine S: Giant cell tumor of the bladder associated with transitional cell carcinoma. J Urol. 133:472–475. 1985.PubMed/NCBI View Article : Google Scholar
16	Dadhania V, Czerniak B and Guo CC: Adenocarcinoma of the urinary bladder. Am J Clin Exp Urol. 3(51)2015.PubMed/NCBI
17	Taguchi S, Akamatsu N, Nakagawa T, Gonoi W, Kanatani A, Miyazaki H, Fujimura T, Fukuhara H, Kume H and Homma Y: Sarcopenia evaluated using the skeletal muscle index is a significant prognostic factor for metastatic urothelial carcinoma. Clin Genitourin Cancer. 14:237–243. 2016.PubMed/NCBI View Article : Google Scholar
18	Ku JH, Byun SS, Jeong H, Kwak C, Kim HH and Lee SE: Lymphovascular invasion as a prognostic factor in the upper urinary tract urothelial carcinoma: A systematic review and meta-analysis. Eur J Cancer. 49:2665–2680. 2013.PubMed/NCBI View Article : Google Scholar
19	Roy S and Parwani : AVA8/arpa.2009-0713-RS adenocarcinoma of the urinary bladder. Arch Pathol Lab Med. 135:1601–1605. 2011.PubMed/NCBI View Article : Google Scholar
20	Lee KH and Song CG: Epigenetic regulation in bladder cancer: Development of new prognostic targets and therapeutic implications. Translational Cancer Res. 30 (Suppl):677–688. 2017.
21	Crabb SJ and Douglas J: The latest treatment options for bladder cancer. Br Med Bull. 128:85–95. 2018.PubMed/NCBI View Article : Google Scholar
22	Witjes JA: Bladder carcinoma in situ in 2003: State of the Art. Eur Urol. 45:142–146. 2004.PubMed/NCBI View Article : Google Scholar
23	Mingomataj E, Krasniqi M, Dedushi K, Sergeevich KA, Kust D and Qadir AA: Cancer Publications in one year (2023): A cross-sectional study. Barw Med J. 2(3)2024.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Urinary bladder collision tumors: A case report and literature review

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Related Articles